Together we will beat cancer

Donate

New leukaemia gene stops blood cells ‘growing up’

Scientists have identified a gene – FOXC1 – that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukaemia (AML) patients

Read More

Cure for young acute myeloid leukaemia patients increases six-fold since 1970s

Almost half of teens and young adults with acute myeloid leukaemia (AML) – a typically aggressive form of leukaemia – are cured thanks to improvements in treatment and care, according to research published in the British Journal of Haematology.

Read More

US researchers unveil womb cancer and acute leukaemia genomes

US researchers have published details of the genetic makeup of two more forms of cancer – acute myeloid leukaemia (AML) and womb (endometrial) cancer.

Read More

Protein that takes care of our DNA is critical to leukaemia cell survival

A protein – already known to be involved in a cell’s response to stress – called Tetratricopeptide repeat domain 5 (TTC5) is critical to the development of acute myeloid leukaemia (AML), according to a new Cancer Research UK study published in Cell Death and Disease

Read More

More than 33,000 childhood cancer survivors living in the UK

An estimated 33,000 long-term survivors of childhood cancer – the vast majority of whom are cured – will be living in the UK by the end of 2012.

Read More

Smart drug improves survival in older patients with acute myeloid leukaemia

Acute Myeloid Leukaemia (AML) patients given a new type of ‘smart drug’ in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent less likely to die from their disease, results from a major phase III Cancer Research UK-funded trial led by Cardiff University show today (Saturday).

Read More

Drug’s ‘double hit’ overcomes leukaemia resistance

A drug that uses a unique ‘double hit’ to kill leukaemia cells could be a potential new treatment for patients with acute myeloid leukaemia. The research, majority funded by Cancer Research UK, is published this week in Leukaemia.

Read More

Trial launched into testosterone replacement for male cancer survivors

Cancer Research UK is today launching a trial to see if male cancer survivors could benefit from hormone replacement therapy (HRT) with testosterone.

Read More

Cancer Research UK launches trial of new drug to treat acute childhood leukaemia

Cancer Research UK’s Drug Development Office has opened the first trial of a new type of leukaemia drug.

Read More

More than five thousand children saved since 70s thanks to better cancer treatment

At least 5,600 more children have survived for at least five years after being diagnosed with cancer than would have done if survival rates had remained as they were in the early 1970s, according to new statistics from Cancer Research UK.

Read More